Summary
Studies in vitro have shown that glycosylation of low density lipoprotein (LDL) will decrease its ability to bind to its receptor. We have evaluated the possibility that such an event might occur in vivo in diabetes by comparing the binding and degradation by normal fibroblasts and mouse peritoneal macrophages of LDL obtained from normal control subjects and patients with Type 2 (non-insulin-dependent) diabetes mellitus. When compared with control subjects, Type 2 diabetic patients had elevated fasting glucose (increased by 160%), haemoglobin A1c (increased by 75%), triglyceride (increased by 550%), and cholesterol (increased by 48%) levels. LDL from Type 2 diabetic patients displayed populations of particles with more heterogeneous hydrated densities than LDL from control subjects, with enrichment in the triglyceride content of the lighter population. 125I-LDL from normal and Type 2 diabetic subjects bound to fibroblasts with similar binding affinities and binding capacities. The kinetics of degradation of LDL from normal and Type 2 diabetic subjects by fibroblasts were also similar. Furthermore, all populations of LDL particles from Type 2 diabetic patients were bound and degraded by normal fibroblasts in identical fashions. In addition, 125I-LDL from normal and Type 2 diabetic subjects were not bound or degraded by mouse peritoneal macrophages. It is concluded that the LDL of patients with Type 2 diabetes with moderate hyperglycaemia are not modified sufficiently to alter their normal binding and degradation by human fibroblasts or to cause their uptake by mouse peritoneal macrophages.
Article PDF
Similar content being viewed by others
References
Goldstein JL, Brown MS (1977) The low density lipoprotein pathway and its relation to atherosclerosis. Ann Rev Biochem 46: 897–930
Basu SK, Goldstein JL, Anderson RGW, Brown MS (1976) Degradation of cationized low density lipoprotein and regulation of cholesterol metabolism in homozygous familial hypercholesterolemia fibroblasts. Proc Natl Acad Sci USA 73: 3178–3182
Weisberger KH, Innerarity TL, Mahley RW (1976) Role of lysine residues of plasma lipoproteins in high affinity binding to cell surface receptors on human fibroblasts. J Biol Chem 253: 9053–9062
Gonen B, Jacobsen D, Farrar P, Schonfeld G (1981) In vitro glycosylation of low density and high density lipoproteins. Diabetes 30: 875–878
Witztum JL, Branks MJ, Steinberg D (1981) Nonenzymatic glycosylation of low density lipoproteins (LDL) interferes with its high affinity receptor uptake by fibroblasts. Clin Res 29: 61 (Abstract)
Kim HJ, Kurup IV (1980) Increased catabolism of glycosylated low density lipoprotein by rat peritoneal macrophage. Diabetes 29 (Suppl 2): 2 (Abstract)
Schleicher E, Deufel T, Wieland OH (1981) Non-enzymatic glycosylation of human serum lipoproteins. Elevated ɛ-lysine glycosylated low density lipoproteins in diabetic patients. FEBS Lett 129: 1–4
Kadish AH, Little RL, Steinberg JC (1968) A new and rapid method for determination of glucose by measurement of rate of oxygen consumption. Clin Chem 14: 116–131
Desbuquois B, Aurbach GD (1971) Use of polyethylene glycol to separate free and antibody bound peptide hormones in radioimmunoassays. J Clin Endocrinol Metab 33: 732–738
Schwartz HC, King KC, Schwartz AL, Edmunds D, Schwartz R (1976) Effects of pregnancy on hemoglobin AIc in normal, gestational diabetic, and diabetic women. Diabetes 25: 1118–1122
Wahlfeld AW (1974) Triglyceride determination after enzymatic hydrolysis. In: Bergmeyer HV (ed) Methods of enzymatic analysis, 2nd edn. Academic Press, New York, pp 1831–1835
Abel LL, Levy BB, Brodie BB, Kendall FE (1952) A simplified method for the estimation of total cholesterol in serum and demonstration of its specificity. J Biol Chem 195: 357–366
Havel RJ, Eder HA, Bragdon JH (1955) The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J Clin Invest 34: 1345–1353
MacFarlane AS (1958) Efficient trace-labelling of proteins with iodine. Nature 182: 53
Goldstein JL, Brown MS (1974) Binding and degradation of low density lipoproteins by cultured human fibroblasts. Comparison of cells from a normal subject and from a patient with homozygous familial hypercholesterolemia. J Biol Chem 249: 5153–5162
Gallily R, Feldman M (1967) The role of macrophages in the induction of antibody in X-irradiated animals. Immunology 12: 197–205
Markwell MAK, Haas SM, Bieber LL, Tolbert NE (1978) A modification of the Lowry procedure to simplify protein determination in membrane and lipoprotein samples. Anal Biochem 87: 206–210
Goldstein JL, Brown MS (1977) Atherosclerosis: the low density lipoprotein receptor hypothesis. Metabolism 26: 1257–1275
Goldstein JL, Ho YK, Basu SK, Brown MS (1979) Binding site on macrophage that mediates uptake and degradation of acetylated low density lipoprotein, producing massive cholesterol deposition. Proc Natl Acad Sci USA 76: 333–337
Mahley RW, Innerarity TL, Pitas RE, Weisgraber HK, Brown JH, Gross E (1977) Inhibition of lipoprotein binding to cell surface receptors of fibroblasts following selective modification of arginyl residues in arginine-rich and B apoproteins. J Biol Chem 252: 7279–7287
Bunn AF, Gabbay HK, Gallop PM (1978) The glycosylation of hemoglobin: relevance to diabetes mellitus. Science 200: 21–27
Lopes-Virella MF, Sherer G, Lees AM, Wohlfmann H, Mayfield R, Sagel J, LeRoy C, Colwell JA (1981) Uptake and degradation by human fibroblasts of LDL isolated from patients. Changes with metabolic control. Clin Res 29: 425A (Abstract)
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Kraemer, F.B., Chen, Y.D.I., Cheung, R.M.C. et al. Are the binding and degradation of low density lipoprotein altered in type 2 (non-insulin-dependent) diabetes mellitus?. Diabetologia 23, 28–33 (1982). https://doi.org/10.1007/BF00257726
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00257726